Advertisement

Optic Nerve Disease in Diabetes Mellitus

  • David J. Browning
Chapter

Abstract

The vascular supply of the optic nerve depends on the stratum of the optic nerve head under consideration. The optic nerve head is divided into four strata – superficial nerve fiber layer, prelaminar layer, laminar layer, and retrolaminar layer. Fine retinal arterioles arising in the peripapillary retina and derived from the central retinal artery supply the superficial nerve fiber layer of the optic nerve; there is no posterior ciliary contribution. 1 The prelaminar and laminar optic nerve derive their blood supply primarily from the paraoptic short posterior ciliary arteries and the circumferential vessels of the circle of Zinn-Haller (Fig. 1).2–5 The circle of Zinn-Haller, where it exists, is an intermediary between the posterior ciliary arteries and the anterior optic nerve small vessels. 1,6 There may be smaller and inconsistent contributions from peripapillary choroidal arteries

Keywords

Optic Nerve Optic Disk Retinal Nerve Fiber Layer Optic Nerve Head Central Retinal Vein Occlusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Onda E, Cioffi GA, Bacon DR, Van Busckirk EM. Microvasculature of the human optic nerve. Am J Ophthalmol. 1995;120:92–102.PubMedGoogle Scholar
  2. 2.
    Henkind P, Levitzky M. Angioarchitecture of the optic nerve I. The papilla. Am J Ophthalmol. 1969;68:979–986.PubMedGoogle Scholar
  3. 3.
    Ernest JT, Potts AM. Pathophysiology of the distal portion of the optic nerve II. Vascular relationships. Am J Ophthalmol. 1968;66:380–387.PubMedGoogle Scholar
  4. 4.
    Gitter KA, Blumenthal M, Best M, Galin MA. Origin of the peripapillary vascular network. Am J Ophthalmol. 1970;69:249–251.PubMedGoogle Scholar
  5. 5.
    Hayreh SS. Posterior ciliary artery circulation in health and disease. The Weisenfeld Lecture. Invest Ophthalmol Vis Sci. 2004;45(3):749–757.CrossRefPubMedGoogle Scholar
  6. 6.
    Anderson DR. Vascular supply to the optic nerve of primates. Am J Ophthalmol. 1970;70:341–351.PubMedGoogle Scholar
  7. 7.
    Lieberman MF, Maumenee AE, Green WR. Histologic studies of the vasculature of the anterior optic nerve. Am J Ophthalmol. 1976;82:405–423.PubMedGoogle Scholar
  8. 8.
    Ruskell G. Blood flow in the Zinn-Haller circle. Br J Ophthalmol. 1998;82:1351.CrossRefPubMedGoogle Scholar
  9. 9.
    Ohno-Matsui K, Futagami S, Yamashita S, Tokoro T. Zinn-Haller arterial ring observed by ICG angiography in high myopia. Br J Ophthalmol. 1998;82:1357–1362.CrossRefPubMedGoogle Scholar
  10. 10.
    Levitsky M, Henkind P. Architecture of the optic nerve II. Lamina cribrosa. Am J Ophthalmol. 1969;68:986–996.Google Scholar
  11. 11.
    Anderson DR. Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol. 1969;82:800–814.PubMedGoogle Scholar
  12. 12.
    Levin LA. Optic nerve. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye. Clinical Application. St. Louis, Mo: Mosby; 2003:603–638.Google Scholar
  13. 13.
    Harris A, Kagemann L, Cioffi GA. Assessment of human ocular hemodynamics. Surv Ophthalmol. 1998;42:509–533.CrossRefPubMedGoogle Scholar
  14. 14.
    Harris A, Cuilla TA, Chung HK, Martin B. Regulation of retinal and optic nerve blood flow. Arch Ophthalmol. 1998;116:1491–1495.PubMedGoogle Scholar
  15. 15.
    Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol. 1999;43:S5–S9.CrossRefPubMedGoogle Scholar
  16. 16.
    Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res. 2001;20:596–624.Google Scholar
  17. 17.
    Rockwood EJ, Fantes F, Davis EB, Anderson DR. The response of retinal vasculature to angiotensin. Invest Ophthalmol Vis Sci. 1987;28:676–682.PubMedGoogle Scholar
  18. 18.
    Hayreh SS, Zimmerman MB, Podhajsky P, Alward WLM. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603–624.PubMedGoogle Scholar
  19. 19.
    Takahashi H, Goto T, Shoji T, et al. Diabetes associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am J Ophthalmol. 2006;142:88–94.CrossRefPubMedGoogle Scholar
  20. 20.
    Klein B, Moss S, Klein R, Magli Y, Hoyer C. Neuroretinal rim area in diabetes mellitus. Invest Ophthalmol Vis Sci. 1990;31:805–809.PubMedGoogle Scholar
  21. 21.
    Cullen J. Pituitary ablation for advancing diabetic retinopathy. E.E.N.T Digest. 1968;47–54.Google Scholar
  22. 22.
    Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2007;114:1763–1772.CrossRefPubMedGoogle Scholar
  23. 23.
    Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: Report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134:317–328.Google Scholar
  24. 24.
    Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:103–107.PubMedGoogle Scholar
  25. 25.
    Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;117:222–230.PubMedGoogle Scholar
  26. 26.
    Levin LA, Danesh-Meyer HV. Hypothesis. A venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008;126:1582–1584.CrossRefPubMedGoogle Scholar
  27. 27.
    Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy VII. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94:1020–1028.PubMedGoogle Scholar
  28. 28.
    Hayreh SS, Podhajsky PA, Zimmerman B. Nonarteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol. 1997;124:641–647.PubMedGoogle Scholar
  29. 29.
    Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1993;116:759–764.PubMedGoogle Scholar
  30. 30.
    Hayreh SS, Zimmerman MB. Optic disk edema in non-arteritic anterior ischemic optic neuropathy. Graefe's Arch Clin Exp Ophthalmol. 2007; 245:1107–1121.CrossRefGoogle Scholar
  31. 31.
    Feit RH, Tomsak RL, Ellenberger C Jr. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol. 1984;98:105–108.CrossRefPubMedGoogle Scholar
  32. 32.
    Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disk structure in anterior ischemic optic neuropathy. Ophthalmology. 1984;91:1334–1337.PubMedGoogle Scholar
  33. 33.
    Cullen JF, Por YM. Ischemic optic neuropathy: the Singapore scene. Singapore Med J. 2007;48:281–286.PubMedGoogle Scholar
  34. 34.
    Sadaba LM, Garcia-Layana A, Maldonado MJ, Berian JM. Bilateral ischemic optic neuropathy after transurethral prostatic resection: a case report. BMC Ophthalmology. 2006;6:32–36.Google Scholar
  35. 35.
    Hayreh SS. Anterior ischemic optic neuropathy VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis. Ophthalmology. 1987;94:1488–1502.PubMedGoogle Scholar
  36. 36.
    Palombi K, Renard E, Levy P, et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol. 2006;90:879–882.CrossRefPubMedGoogle Scholar
  37. 37.
    Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983;96:478–483.PubMedGoogle Scholar
  38. 38.
    Behbehani R, Matthews MK, Sergot RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol. 2005;139:518–521.CrossRefPubMedGoogle Scholar
  39. 39.
    Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1994;118:766–780.PubMedGoogle Scholar
  40. 40.
    Mansour AM, Awwad ST, Najjar DM, et al. Anterior ischemic optic neuropathy after coronary artery bypass graft: the role of anemia in diabetics. Eye. 2006;20:706–711.CrossRefPubMedGoogle Scholar
  41. 41.
    Jacobson DM, Vierkant RA, Belongias EA. Nonarteritic canterior ischemic optic neuropathy. A case-control study of potential risk factors. Arch Ophthalmol. 1997;115:1403–1407.PubMedGoogle Scholar
  42. 42.
    Mojon DS, Hedges TR III, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2002;120:601–605.PubMedGoogle Scholar
  43. 43.
    McCulley TJ, Lam BL, Feuer WJ. Incidence of nonarteritic anterior ischemic optic neuropathy associated with cataract extraction. Ophthalmology. 2001;108:1275–1278.CrossRefPubMedGoogle Scholar
  44. 44.
    Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 1999;106:739–742.CrossRefPubMedGoogle Scholar
  45. 45.
    Feldon SE. Anterior ischemic optic neuropathy: trouble waiting to happen. Ophthalmology. 1999;106:651–652.CrossRefPubMedGoogle Scholar
  46. 46.
    Nagy V, Steiber Z, Takacs L, et al. Thrombophilic screening for nonarteritic anterior ischemic optic neuropathy. Graefe's Arch Clin Exp Ophthalmol. 2006;244:3–8.CrossRefGoogle Scholar
  47. 47.
    Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy. Their pattern and prevalence at initial examination. Arch Ophthalmol. 2005;123:1554–1562.CrossRefPubMedGoogle Scholar
  48. 48.
    Burde RM, Slamovits T. Asymptomatic optic disc edema. J Neuro-ophthalmology. 1997;17:29–32.Google Scholar
  49. 49.
    Hayreh SS. Anterior ischemic optic neuropathy V. Optic disk edema an early sign. Arch Ophthalmol. 1981;99:1030–1040.PubMedGoogle Scholar
  50. 50.
    Almog Y, Goldstein M. Visual outcome in eyes with asymptomatic optic disk edema. J Neuro-ophthalmol. 2003;23:204–207.CrossRefGoogle Scholar
  51. 51.
    Borchert M, Lessell S. Progressive and recurrent nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 1988;106:443–449.Google Scholar
  52. 52.
    Beck RW, Savino PJ, Schatz NJ, et al. Anterior ischemic optic neuropathy: recurrent episodes in the same eye. Br J Ophthalmol. 1983;67:705–709.CrossRefPubMedGoogle Scholar
  53. 53.
    Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: clinical characteristics in diabetic patients versus nondiabetic patients. Ophthalmology. 2008;115:1818–1825.CrossRefPubMedGoogle Scholar
  54. 54.
    Hayreh SS. Non-arteritic anterior ischaemic optic neuropathy and phosphodiesterase-5 inhibitors. Br J Ophthalmol. 2008;92:1577–1580.CrossRefPubMedGoogle Scholar
  55. 55.
    Escaravage GK, Wright JD Jr, Givre SJ. Tadalafil associated with anterior ischemic optic neuropathy. Arch Ophthalmol. 2005;123:399–400.CrossRefPubMedGoogle Scholar
  56. 56.
    Pomeranz HD, Smith KH, Hart WM Jr, Egan RA. Sildenafil-associated nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2002;109:584–587.CrossRefPubMedGoogle Scholar
  57. 57.
    Bollinger K, Lee MS. Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge. Arch Ophthalmol. 2005;123:400–401.CrossRefPubMedGoogle Scholar
  58. 58.
    Landau K, Winterkorn JMS, Mailloux LU, Vetter W, Napolitano B. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol. 1996;114:570–575.PubMedGoogle Scholar
  59. 59.
    Hayreh SS, Podhajsky P, Zimmerman MB. Beta-blocker eyedrops and nocturnal arterial hypotension. Am J Ophthalmol. 1999;128:301–309.CrossRefPubMedGoogle Scholar
  60. 60.
    Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol. 2001;132:743–750.CrossRefPubMedGoogle Scholar
  61. 61.
    Arnold A. Anterior ischemic optic neuropathy. Sem Ophthalmol. 1995;10:221–233.CrossRefGoogle Scholar
  62. 62.
    The Ischemic-Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA. 1995;273:625–632.Google Scholar
  63. 63.
    Johnson LN, Gould TJ, Krohel GB. Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration. Am J Ophthalmol. 1996;121:77–83.PubMedGoogle Scholar
  64. 64.
    Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1996;122:535–541.PubMedGoogle Scholar
  65. 65.
    Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:212–217.PubMedGoogle Scholar
  66. 66.
    Botelho PJ, Johnson LN, Arnold AC. The effect of aspirin on the visual outcome of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1996;121:450–451.PubMedGoogle Scholar
  67. 67.
    Lubow M, Makley TA. Pseudopapilledema of juvenile diabetes mellitus. Arch Ophthalmol. 1971;85:417–422.PubMedGoogle Scholar
  68. 68.
    Pavan P, Aiello L, Wafai M, Briones J, Sebestyen J, Bradbury M. Optic disc edema in juvenile-onset diabetes. Arch Ophthalmol. 1980;98:2193–2195.PubMedGoogle Scholar
  69. 69.
    Barr CC, Glaser JS, Blankenship G. Acute disc swelling in juvenile diabetes: a clinical profile and natural history of 12 cases. Arch Ophthalmol. 1980;98:2185–2192.PubMedGoogle Scholar
  70. 70.
    Regillo C, Brown G, Savino P, et al. Diabetic papillopathy: patient characteristics and fundus findings. Arch Ophthalmol. 1995;113:889–895.PubMedGoogle Scholar
  71. 71.
    Valphiades MS. The disk edema dilemma. Surv Ophthalmol. 2002;47:183–188.CrossRefGoogle Scholar
  72. 72.
    Hayreh SS, Zahoruk RM. Anterior ischemic optic neuropathy VI. In juvenile diabetics. Ophthalmologica. 1981;182:13–28.CrossRefPubMedGoogle Scholar
  73. 73.
    Bayraktar Z, Alacali N, Bayraktar S. Diabetic papillopathy in type 2 diabetic patients. Retina. 2002;22:752–758.CrossRefPubMedGoogle Scholar
  74. 74.
    de Ungria JM, Del Priore LV, Hart W. Abnormal disk vessels after diabetic papillopathy. Arch Ophthalmol. 1995;113:245–246.PubMedGoogle Scholar
  75. 75.
    Ward SC, Woods DR, Gilstrap LC III, Hauth JC. Pregnancy and acute optic disc edema of juvenile-onset diabetes. Obstet Gynecol. 1984;64:816–818.PubMedGoogle Scholar
  76. 76.
    Katz B. Disc swelling in an adult diabetic patient. Surv Ophthalmol. 1990;35:158–163.CrossRefPubMedGoogle Scholar
  77. 77.
    Ho AC, Maguire AM, Yanuzzi LA, et al. Rapidly progressive optic disk neovascularization after diabetic papillopathy. Am J Ophthalmol. 1995;120:673–675.PubMedGoogle Scholar
  78. 78.
    Friedrich Y, Feiner M, Gawi H, Friedman Z. Diabetic papillopathy with macular star mimicking clinically significant diabetic macular edema. Retina. 2001;21:80–82.CrossRefPubMedGoogle Scholar
  79. 79.
    Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103:1796–1806.Google Scholar
  80. 80.
    Appen RE, Chandra SR, Klein R, Myers FL. Diabetic papillopathy. Am J Ophthalmol. 1980;90:203–209.PubMedGoogle Scholar
  81. 81.
    Schatz H, McDonald HR, Johnson RN. Diagnostic and therapeutic challenges. Retina. 1998;18:67–69.PubMedGoogle Scholar
  82. 82.
    Saito Y, Ueki N, Hamanaka N, et al. Transient optic disk edema by vitreous traction in a quiescent eye with proliferative diabetic retinopathy mimicking diabetic papillopathy. Retina. 2005;25:83–84.CrossRefPubMedGoogle Scholar
  83. 83.
    Landau K, Bajka JD, Kirchschlager BM. Topless optic disks in children of mothers with type I diabetes mellitus. Am J Ophthalmol. 1998;125:605–611.CrossRefPubMedGoogle Scholar
  84. 84.
    Han SB, Park KH, Kim DM, Kim TW. Prevalence of superior segmental optic nerve hypoplasia in Korea. Jpn J Ophthalmol. 2009;53:225–228.CrossRefPubMedGoogle Scholar
  85. 85.
    Hayashi K, Tomidokoro A, Aihara M, et al. Long-term follow-up of superior segmental optic hypoplasia. Jpn J Ophthalmol. 2008;52:412–414.CrossRefPubMedGoogle Scholar
  86. 86.
    Foroozan R. Superior segmental optic nerve hypoplasia and diabetes mellitus. J Diabetes Complications. 2005;19:165–167.CrossRefPubMedGoogle Scholar
  87. 87.
    Yamamoto T, Sato M, Iwase A. Superior segmental optic hypoplasia found in tajimi eye health care project participants. Jpn J Ophthalmol. 2004;48:578–583.CrossRefPubMedGoogle Scholar
  88. 88.
    Unoki K, Ohba N, Hoyt WF. Optical coherence tomography of superior segmental optic hypoplasia. Br J Ophthalmol. 2002;86:910–914.CrossRefPubMedGoogle Scholar
  89. 89.
    Brodsky MC, Schroeder GT, Ford R. Superior segmental optic hypoplasia in identical twins. J Clin Neuro-ophthalmol. 1993;13:152–154.Google Scholar
  90. 90.
    Sowka J, Vollmer L, Reynolds S. Superior segmental optic nerve hypoplasia: the topless disc syndrome 70. Optometry. 2008;79:576–580.PubMedGoogle Scholar
  91. 91.
    Genis D, Davalos A, Molins A, Ferrer I. Wolfram syndrome: a neuropathological study. Acta Neuropathol. 1997;93:426–429.CrossRefPubMedGoogle Scholar
  92. 92.
    Van den Ouweland JMW, Cryns K, Pennings RJE, et al. Molecular characterization of WFS1 in patients with Wolfram Syndrome. J Mol Diagn. 2003;5:88–95.Google Scholar
  93. 93.
    Galluzzi P, Filosomi G, Vallone IM, Bardelli AM, Venturi C. MRI of wolfram syndrome (DIDMOAD). Neuroradiology. 1999;41:729–731.CrossRefPubMedGoogle Scholar
  94. 94.
    Hong J, Zhang YW, Zhang HJ, et al. The novel compound heterozygous mutations, V434del and W666X, in WFS1 gene causing Wolfram syndrome in a Chinese family. Endocrine. 2009;35:151–157.CrossRefPubMedGoogle Scholar
  95. 95.
    Barrett TG, Bundey SE, Fiedler AR, Good PA. Optic atrophy in Wolfram (DIDMOAD) Syndrome. Eye. 1997;11:882–888.PubMedGoogle Scholar
  96. 96.
    Ajlouni K, Jarrah N, El-Khateeb M, et al. Wolfram Syndrome: identification of a phenotypic and genotypic variant from Jordan. Am J Med Genet. 2002;115:61–65.CrossRefPubMedGoogle Scholar
  97. 97.
    Barrientos A, Volpini V, Casademont J, et al. A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome. J Clin Invest. 1996;97:1570–1576.CrossRefPubMedGoogle Scholar
  98. 98.
    Wake DJ, Jadhav V, Whittome LR, Campbell IW. Wolfram syndrome: DIDMOAD. Br J Diabetes Vasc Dis. 2005;5:236–237.CrossRefGoogle Scholar
  99. 99.
    Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment for macular edema in central retinal vein occlusion: a short term study. Retina. 2006;26:279–284.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Charlotte Eye Ear Nose & Throat AssociatesCharlotteUSA

Personalised recommendations